- Remove All
- Your shopping cart is currently empty
AP-III-a4 hydrochloride (ENOblock hydrochloride) is a novel small molecule which is the first, nonsubstrate analogue that directly binds to enolase and inhibits its activity (IC50=0.576 uM); inhibit cancer cell metastasis in vivo. IC50 value: 0.576 uM [1] Target: enolase Enolase is a component of the glycolysis pathway and a "moonlighting" protein, with important roles in diverse cellular processes that are not related to its function in glycolysis. However, small molecule tools to probe enolase function have been restricted to crystallography or enzymology. ENOblock is the first reported enolase inhibitor that is suitable for biological assays. This new chemical tool may also be suitable for further study as a cancer and diabetes drug candidate.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $98 | Backorder | |
5 mg | $188 | Backorder | |
10 mg | $302 | Backorder | |
25 mg | $619 | Backorder | |
50 mg | $873 | Backorder | |
100 mg | Inquiry | Backorder | |
200 mg | Inquiry | Backorder | |
1 mL x 10 mM (in DMSO) | $260 | Backorder |
Description | AP-III-a4 hydrochloride (ENOblock hydrochloride) is a novel small molecule which is the first, nonsubstrate analogue that directly binds to enolase and inhibits its activity (IC50=0.576 uM); inhibit cancer cell metastasis in vivo. IC50 value: 0.576 uM [1] |
Alias | ENOblock hydrochloride, AP-III-a4 hydrochloride |
Molecular Weight | 631.18 |
Formula | C31H44ClFN8O3 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 53 mg/mL (83.97 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.